NIH-funded research R01 grant

Investigating how a specific protein affects gene expression in heart cells.

Official title: Post-Transcriptional Regulation of Gene Expression by Ribosome-Binding Protein 1

Funded at University of Arizona · NIH-11087711 · Data updated 2026-11-12

This study is looking at how a protein called RRBP1 helps control the way heart muscle cells make important proteins, especially after heart injuries, to find new ways to help the heart heal and work better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Arizona
NIH-funded
Lab location1 site (Tucson, United States)
Project startMay 10, 2024
Project endApril 30, 2029
Funding year2025
Award (this year)$740,143
NIH project number5R01HL170223-02
Project IDNIH-11087711 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with cardiac diseases or those who have experienced myocardial infarction.

Less likely to help

Patients with non-cardiac conditions or those without any history of heart disease may not benefit from this research.

What this research studies

This research focuses on understanding the role of ribosome-binding protein 1 (RRBP1) in regulating gene expression at the post-transcriptional level in cardiac myocytes, which are the muscle cells of the heart. The study aims to explore how RRBP1 interacts with RNA in the endoplasmic reticulum (ER) to influence the production of secretory proteins that are crucial for heart function. By examining the effects of RRBP1 on cardiac health, particularly after events like myocardial infarction, the research seeks to uncover new mechanisms that could improve heart recovery and function. Patients may benefit from insights gained about how to enhance cardiac repair processes through targeted protein regulation.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for improving heart function and recovery after cardiac injuries.

How similar studies have gone: While the specific focus on RRBP1 is novel, previous studies have shown success in understanding post-transcriptional regulation in other contexts, suggesting potential for impactful findings.

Where this research is happening

  • University of Arizona
    Tucson, United States
    Active

Researchers

  • Principal investigator: Doroudgar, Shirin — University of Arizona
  • Study coordinator: Doroudgar, Shirin

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.